# A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions

> **NCT02428036** · PHASE1 · COMPLETED · sponsor: **Takara Bio Inc.** · enrollment: 6 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** TBI-1401(HF10)
- **BIOLOGICAL:** TBI-1401(HF10)

## Key facts

- **NCT ID:** NCT02428036
- **Lead sponsor:** Takara Bio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-10
- **Final completion:** 2017-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02428036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02428036, "A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02428036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*